0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemostatic Forceps Market Research Report 2026
Published Date: 2026-01-30
|
Report Code: QYRE-Auto-13U572
Home | Market Reports
Global Hemostatic Forceps Market Research Report 2020
BUY CHAPTERS

Global Hemostatic Forceps Market Research Report 2026

Code: QYRE-Auto-13U572
Report
2026-01-30
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemostatic Forceps Market Size

The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.

Hemostatic Forceps Market

Hemostatic Forceps Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hemostatic Forceps competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.
In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.
This report delivers a comprehensive overview of the global Hemostatic Forceps market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemostatic Forceps. The Hemostatic Forceps market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hemostatic Forceps market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hemostatic Forceps manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hemostatic Forceps Market Report

Report Metric Details
Report Name Hemostatic Forceps Market
Accounted market size in 2025 US$ 67.75 million
Forecasted market size in 2032 US$ 90.6 million
CAGR 4.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Halstead Mosquito Hemostatic Forceps
  • Kelly and Crile Hemostatic Forceps
  • Rochester-Carmalt Hemostatic Forceps
by Application
  • Surgical
  • Dissection
  • Dental
  • Laparoscopic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medline, B. Braun, CareFusion, Asa Dental, Sklar, Scanlan International, Shanghai Medical Instruments, Lawton, Hu-Friedy, Xinhua Surgical, Towne Brothers, Teleflex Medical, Delacroix Chevalier, YDM, M A Corporation, MedGyn Products, Inami, Ted Pella, Medicon eG, J & J Instruments, American Diagnostic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Hemostatic Forceps manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Hemostatic Forceps sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Hemostatic Forceps Market growing?

Ans: The Hemostatic Forceps Market witnessing a CAGR of 4.3% during the forecast period 2026-2032.

What is the Hemostatic Forceps Market size in 2032?

Ans: The Hemostatic Forceps Market size in 2032 will be US$ 90.6 million.

What is the market share of major companies in Hemostatic Forceps Market?

Ans: Global top five manufacturers hold a share over 45%.

What is the Hemostatic Forceps Market share by type?

Ans: In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.

Who are the main players in the Hemostatic Forceps Market report?

Ans: The main players in the Hemostatic Forceps Market are Medline, B. Braun, CareFusion, Asa Dental, Sklar, Scanlan International, Shanghai Medical Instruments, Lawton, Hu-Friedy, Xinhua Surgical, Towne Brothers, Teleflex Medical, Delacroix Chevalier, YDM, M A Corporation, MedGyn Products, Inami, Ted Pella, Medicon eG, J & J Instruments, American Diagnostic

What are the Application segmentation covered in the Hemostatic Forceps Market report?

Ans: The Applications covered in the Hemostatic Forceps Market report are Surgical, Dissection, Dental, Laparoscopic, Others

What are the Type segmentation covered in the Hemostatic Forceps Market report?

Ans: The Types covered in the Hemostatic Forceps Market report are Halstead Mosquito Hemostatic Forceps, Kelly and Crile Hemostatic Forceps, Rochester-Carmalt Hemostatic Forceps

1 Hemostatic Forceps Market Overview
1.1 Product Definition
1.2 Hemostatic Forceps by Type
1.2.1 Global Hemostatic Forceps Market Value by Type: 2025 vs 2032
1.2.2 Halstead Mosquito Hemostatic Forceps
1.2.3 Kelly and Crile Hemostatic Forceps
1.2.4 Rochester-Carmalt Hemostatic Forceps
1.3 Hemostatic Forceps by Application
1.3.1 Global Hemostatic Forceps Market Value by Application: 2025 vs 2032
1.3.2 Surgical
1.3.3 Dissection
1.3.4 Dental
1.3.5 Laparoscopic
1.3.6 Others
1.4 Global Hemostatic Forceps Market Size Estimates and Forecasts
1.4.1 Global Hemostatic Forceps Revenue 2021–2032
1.4.2 Global Hemostatic Forceps Sales 2021–2032
1.4.3 Global Hemostatic Forceps Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Hemostatic Forceps Market Competition by Manufacturers
2.1 Global Hemostatic Forceps Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hemostatic Forceps Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hemostatic Forceps Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hemostatic Forceps, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hemostatic Forceps, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hemostatic Forceps, Product Types and Applications
2.7 Global Key Manufacturers of Hemostatic Forceps, Date of Entry into the Industry
2.8 Global Hemostatic Forceps Market Competitive Situation and Trends
2.8.1 Global Hemostatic Forceps Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hemostatic Forceps Players Market Share by Revenue
2.8.3 Global Hemostatic Forceps Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostatic Forceps Market Scenario by Region
3.1 Global Hemostatic Forceps Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hemostatic Forceps Sales by Region: 2021–2032
3.2.1 Global Hemostatic Forceps Sales by Region: 2021–2026
3.2.2 Global Hemostatic Forceps Sales by Region: 2027–2032
3.3 Global Hemostatic Forceps Revenue by Region: 2021–2032
3.3.1 Global Hemostatic Forceps Revenue by Region: 2021–2026
3.3.2 Global Hemostatic Forceps Revenue by Region: 2027–2032
3.4 North America Hemostatic Forceps Market Facts & Figures by Country
3.4.1 North America Hemostatic Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hemostatic Forceps Sales by Country (2021–2032)
3.4.3 North America Hemostatic Forceps Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic Forceps Market Facts & Figures by Country
3.5.1 Europe Hemostatic Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hemostatic Forceps Sales by Country (2021–2032)
3.5.3 Europe Hemostatic Forceps Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic Forceps Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostatic Forceps Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hemostatic Forceps Sales by Region (2021–2032)
3.6.3 Asia Pacific Hemostatic Forceps Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostatic Forceps Market Facts & Figures by Country
3.7.1 Latin America Hemostatic Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hemostatic Forceps Sales by Country (2021–2032)
3.7.3 Latin America Hemostatic Forceps Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic Forceps Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hemostatic Forceps Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hemostatic Forceps Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostatic Forceps Sales by Type (2021–2032)
4.1.1 Global Hemostatic Forceps Sales by Type (2021–2026)
4.1.2 Global Hemostatic Forceps Sales by Type (2027–2032)
4.1.3 Global Hemostatic Forceps Sales Market Share by Type (2021–2032)
4.2 Global Hemostatic Forceps Revenue by Type (2021–2032)
4.2.1 Global Hemostatic Forceps Revenue by Type (2021–2026)
4.2.2 Global Hemostatic Forceps Revenue by Type (2027–2032)
4.2.3 Global Hemostatic Forceps Revenue Market Share by Type (2021–2032)
4.3 Global Hemostatic Forceps Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hemostatic Forceps Sales by Application (2021–2032)
5.1.1 Global Hemostatic Forceps Sales by Application (2021–2026)
5.1.2 Global Hemostatic Forceps Sales by Application (2027–2032)
5.1.3 Global Hemostatic Forceps Sales Market Share by Application (2021–2032)
5.2 Global Hemostatic Forceps Revenue by Application (2021–2032)
5.2.1 Global Hemostatic Forceps Revenue by Application (2021–2026)
5.2.2 Global Hemostatic Forceps Revenue by Application (2027–2032)
5.2.3 Global Hemostatic Forceps Revenue Market Share by Application (2021–2032)
5.3 Global Hemostatic Forceps Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medline
6.1.1 Medline Company Information
6.1.2 Medline Description and Business Overview
6.1.3 Medline Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medline Hemostatic Forceps Product Portfolio
6.1.5 Medline Recent Developments/Updates
6.2 B. Braun
6.2.1 B. Braun Company Information
6.2.2 B. Braun Description and Business Overview
6.2.3 B. Braun Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 B. Braun Hemostatic Forceps Product Portfolio
6.2.5 B. Braun Recent Developments/Updates
6.3 CareFusion
6.3.1 CareFusion Company Information
6.3.2 CareFusion Description and Business Overview
6.3.3 CareFusion Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CareFusion Hemostatic Forceps Product Portfolio
6.3.5 CareFusion Recent Developments/Updates
6.4 Asa Dental
6.4.1 Asa Dental Company Information
6.4.2 Asa Dental Description and Business Overview
6.4.3 Asa Dental Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Asa Dental Hemostatic Forceps Product Portfolio
6.4.5 Asa Dental Recent Developments/Updates
6.5 Sklar
6.5.1 Sklar Company Information
6.5.2 Sklar Description and Business Overview
6.5.3 Sklar Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sklar Hemostatic Forceps Product Portfolio
6.5.5 Sklar Recent Developments/Updates
6.6 Scanlan International
6.6.1 Scanlan International Company Information
6.6.2 Scanlan International Description and Business Overview
6.6.3 Scanlan International Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Scanlan International Hemostatic Forceps Product Portfolio
6.6.5 Scanlan International Recent Developments/Updates
6.7 Shanghai Medical Instruments
6.7.1 Shanghai Medical Instruments Company Information
6.7.2 Shanghai Medical Instruments Description and Business Overview
6.7.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shanghai Medical Instruments Hemostatic Forceps Product Portfolio
6.7.5 Shanghai Medical Instruments Recent Developments/Updates
6.8 Lawton
6.8.1 Lawton Company Information
6.8.2 Lawton Description and Business Overview
6.8.3 Lawton Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Lawton Hemostatic Forceps Product Portfolio
6.8.5 Lawton Recent Developments/Updates
6.9 Hu-Friedy
6.9.1 Hu-Friedy Company Information
6.9.2 Hu-Friedy Description and Business Overview
6.9.3 Hu-Friedy Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hu-Friedy Hemostatic Forceps Product Portfolio
6.9.5 Hu-Friedy Recent Developments/Updates
6.10 Xinhua Surgical
6.10.1 Xinhua Surgical Company Information
6.10.2 Xinhua Surgical Description and Business Overview
6.10.3 Xinhua Surgical Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Xinhua Surgical Hemostatic Forceps Product Portfolio
6.10.5 Xinhua Surgical Recent Developments/Updates
6.11 Towne Brothers
6.11.1 Towne Brothers Company Information
6.11.2 Towne Brothers Description and Business Overview
6.11.3 Towne Brothers Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Towne Brothers Hemostatic Forceps Product Portfolio
6.11.5 Towne Brothers Recent Developments/Updates
6.12 Teleflex Medical
6.12.1 Teleflex Medical Company Information
6.12.2 Teleflex Medical Description and Business Overview
6.12.3 Teleflex Medical Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Teleflex Medical Hemostatic Forceps Product Portfolio
6.12.5 Teleflex Medical Recent Developments/Updates
6.13 Delacroix Chevalier
6.13.1 Delacroix Chevalier Company Information
6.13.2 Delacroix Chevalier Description and Business Overview
6.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Delacroix Chevalier Hemostatic Forceps Product Portfolio
6.13.5 Delacroix Chevalier Recent Developments/Updates
6.14 YDM
6.14.1 YDM Company Information
6.14.2 YDM Description and Business Overview
6.14.3 YDM Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 YDM Hemostatic Forceps Product Portfolio
6.14.5 YDM Recent Developments/Updates
6.15 M A Corporation
6.15.1 M A Corporation Company Information
6.15.2 M A Corporation Description and Business Overview
6.15.3 M A Corporation Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 M A Corporation Hemostatic Forceps Product Portfolio
6.15.5 M A Corporation Recent Developments/Updates
6.16 MedGyn Products
6.16.1 MedGyn Products Company Information
6.16.2 MedGyn Products Description and Business Overview
6.16.3 MedGyn Products Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 MedGyn Products Hemostatic Forceps Product Portfolio
6.16.5 MedGyn Products Recent Developments/Updates
6.17 Inami
6.17.1 Inami Company Information
6.17.2 Inami Description and Business Overview
6.17.3 Inami Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Inami Hemostatic Forceps Product Portfolio
6.17.5 Inami Recent Developments/Updates
6.18 Ted Pella
6.18.1 Ted Pella Company Information
6.18.2 Ted Pella Description and Business Overview
6.18.3 Ted Pella Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Ted Pella Hemostatic Forceps Product Portfolio
6.18.5 Ted Pella Recent Developments/Updates
6.19 Medicon eG
6.19.1 Medicon eG Company Information
6.19.2 Medicon eG Description and Business Overview
6.19.3 Medicon eG Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Medicon eG Hemostatic Forceps Product Portfolio
6.19.5 Medicon eG Recent Developments/Updates
6.20 J & J Instruments
6.20.1 J & J Instruments Company Information
6.20.2 J & J Instruments Description and Business Overview
6.20.3 J & J Instruments Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 J & J Instruments Hemostatic Forceps Product Portfolio
6.20.5 J & J Instruments Recent Developments/Updates
6.21 American Diagnostic
6.21.1 American Diagnostic Company Information
6.21.2 American Diagnostic Description and Business Overview
6.21.3 American Diagnostic Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 American Diagnostic Hemostatic Forceps Product Portfolio
6.21.5 American Diagnostic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic Forceps Industry Chain Analysis
7.2 Hemostatic Forceps Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic Forceps Production Mode & Process Analysis
7.4 Hemostatic Forceps Sales and Marketing
7.4.1 Hemostatic Forceps Sales Channels
7.4.2 Hemostatic Forceps Distributors
7.5 Hemostatic Forceps Customer Analysis
8 Hemostatic Forceps Market Dynamics
8.1 Hemostatic Forceps Industry Trends
8.2 Hemostatic Forceps Market Drivers
8.3 Hemostatic Forceps Market Challenges
8.4 Hemostatic Forceps Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hemostatic Forceps Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Hemostatic Forceps Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Hemostatic Forceps Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Hemostatic Forceps Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Hemostatic Forceps Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Hemostatic Forceps Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Hemostatic Forceps Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Hemostatic Forceps Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Hemostatic Forceps, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Hemostatic Forceps, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Hemostatic Forceps, Product Types and Applications
 Table 12. Global Key Manufacturers of Hemostatic Forceps, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hemostatic Forceps Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hemostatic Forceps Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hemostatic Forceps Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Hemostatic Forceps Sales by Region (K Units), 2021–2026
 Table 18. Global Hemostatic Forceps Sales Market Share by Region (2021–2026)
 Table 19. Global Hemostatic Forceps Sales by Region (K Units), 2027–2032
 Table 20. Global Hemostatic Forceps Sales Market Share by Region (2027–2032)
 Table 21. Global Hemostatic Forceps Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Hemostatic Forceps Revenue Market Share by Region (2021–2026)
 Table 23. Global Hemostatic Forceps Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Hemostatic Forceps Revenue Market Share by Region (2027–2032)
 Table 25. North America Hemostatic Forceps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Hemostatic Forceps Sales by Country (K Units), 2021–2026
 Table 27. North America Hemostatic Forceps Sales by Country (K Units), 2027–2032
 Table 28. North America Hemostatic Forceps Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Hemostatic Forceps Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Hemostatic Forceps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Hemostatic Forceps Sales by Country (K Units), 2021–2026
 Table 32. Europe Hemostatic Forceps Sales by Country (K Units), 2027–2032
 Table 33. Europe Hemostatic Forceps Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Hemostatic Forceps Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Hemostatic Forceps Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Hemostatic Forceps Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Hemostatic Forceps Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Hemostatic Forceps Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Hemostatic Forceps Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Hemostatic Forceps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Hemostatic Forceps Sales by Country (K Units), 2021–2026
 Table 42. Latin America Hemostatic Forceps Sales by Country (K Units), 2027–2032
 Table 43. Latin America Hemostatic Forceps Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Hemostatic Forceps Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Hemostatic Forceps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Hemostatic Forceps Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Hemostatic Forceps Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Hemostatic Forceps Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Hemostatic Forceps Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Hemostatic Forceps Sales (K Units) by Type (2021–2026)
 Table 51. Global Hemostatic Forceps Sales (K Units) by Type (2027–2032)
 Table 52. Global Hemostatic Forceps Sales Market Share by Type (2021–2026)
 Table 53. Global Hemostatic Forceps Sales Market Share by Type (2027–2032)
 Table 54. Global Hemostatic Forceps Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Hemostatic Forceps Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Hemostatic Forceps Revenue Market Share by Type (2021–2026)
 Table 57. Global Hemostatic Forceps Revenue Market Share by Type (2027–2032)
 Table 58. Global Hemostatic Forceps Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Hemostatic Forceps Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Hemostatic Forceps Sales (K Units) by Application (2021–2026)
 Table 61. Global Hemostatic Forceps Sales (K Units) by Application (2027–2032)
 Table 62. Global Hemostatic Forceps Sales Market Share by Application (2021–2026)
 Table 63. Global Hemostatic Forceps Sales Market Share by Application (2027–2032)
 Table 64. Global Hemostatic Forceps Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Hemostatic Forceps Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Hemostatic Forceps Revenue Market Share by Application (2021–2026)
 Table 67. Global Hemostatic Forceps Revenue Market Share by Application (2027–2032)
 Table 68. Global Hemostatic Forceps Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Hemostatic Forceps Price (USD/Unit) by Application (2027–2032)
 Table 70. Medline Company Information
 Table 71. Medline Description and Business Overview
 Table 72. Medline Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Medline Hemostatic Forceps Product
 Table 74. Medline Recent Developments/Updates
 Table 75. B. Braun Company Information
 Table 76. B. Braun Description and Business Overview
 Table 77. B. Braun Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. B. Braun Hemostatic Forceps Product
 Table 79. B. Braun Recent Developments/Updates
 Table 80. CareFusion Company Information
 Table 81. CareFusion Description and Business Overview
 Table 82. CareFusion Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. CareFusion Hemostatic Forceps Product
 Table 84. CareFusion Recent Developments/Updates
 Table 85. Asa Dental Company Information
 Table 86. Asa Dental Description and Business Overview
 Table 87. Asa Dental Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Asa Dental Hemostatic Forceps Product
 Table 89. Asa Dental Recent Developments/Updates
 Table 90. Sklar Company Information
 Table 91. Sklar Description and Business Overview
 Table 92. Sklar Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Sklar Hemostatic Forceps Product
 Table 94. Sklar Recent Developments/Updates
 Table 95. Scanlan International Company Information
 Table 96. Scanlan International Description and Business Overview
 Table 97. Scanlan International Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Scanlan International Hemostatic Forceps Product
 Table 99. Scanlan International Recent Developments/Updates
 Table 100. Shanghai Medical Instruments Company Information
 Table 101. Shanghai Medical Instruments Description and Business Overview
 Table 102. Shanghai Medical Instruments Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Shanghai Medical Instruments Hemostatic Forceps Product
 Table 104. Shanghai Medical Instruments Recent Developments/Updates
 Table 105. Lawton Company Information
 Table 106. Lawton Description and Business Overview
 Table 107. Lawton Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Lawton Hemostatic Forceps Product
 Table 109. Lawton Recent Developments/Updates
 Table 110. Hu-Friedy Company Information
 Table 111. Hu-Friedy Description and Business Overview
 Table 112. Hu-Friedy Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Hu-Friedy Hemostatic Forceps Product
 Table 114. Hu-Friedy Recent Developments/Updates
 Table 115. Xinhua Surgical Company Information
 Table 116. Xinhua Surgical Description and Business Overview
 Table 117. Xinhua Surgical Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Xinhua Surgical Hemostatic Forceps Product
 Table 119. Xinhua Surgical Recent Developments/Updates
 Table 120. Towne Brothers Company Information
 Table 121. Towne Brothers Description and Business Overview
 Table 122. Towne Brothers Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Towne Brothers Hemostatic Forceps Product
 Table 124. Towne Brothers Recent Developments/Updates
 Table 125. Teleflex Medical Company Information
 Table 126. Teleflex Medical Description and Business Overview
 Table 127. Teleflex Medical Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Teleflex Medical Hemostatic Forceps Product
 Table 129. Teleflex Medical Recent Developments/Updates
 Table 130. Delacroix Chevalier Company Information
 Table 131. Delacroix Chevalier Description and Business Overview
 Table 132. Delacroix Chevalier Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Delacroix Chevalier Hemostatic Forceps Product
 Table 134. Delacroix Chevalier Recent Developments/Updates
 Table 135. YDM Company Information
 Table 136. YDM Description and Business Overview
 Table 137. YDM Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. YDM Hemostatic Forceps Product
 Table 139. YDM Recent Developments/Updates
 Table 140. M A Corporation Company Information
 Table 141. M A Corporation Description and Business Overview
 Table 142. M A Corporation Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 143. M A Corporation Hemostatic Forceps Product
 Table 144. M A Corporation Recent Developments/Updates
 Table 145. MedGyn Products Company Information
 Table 146. MedGyn Products Description and Business Overview
 Table 147. MedGyn Products Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 148. MedGyn Products Hemostatic Forceps Product
 Table 149. MedGyn Products Recent Developments/Updates
 Table 150. Inami Company Information
 Table 151. Inami Description and Business Overview
 Table 152. Inami Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 153. Inami Hemostatic Forceps Product
 Table 154. Inami Recent Developments/Updates
 Table 155. Ted Pella Company Information
 Table 156. Ted Pella Description and Business Overview
 Table 157. Ted Pella Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 158. Ted Pella Hemostatic Forceps Product
 Table 159. Ted Pella Recent Developments/Updates
 Table 160. Medicon eG Company Information
 Table 161. Medicon eG Description and Business Overview
 Table 162. Medicon eG Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 163. Medicon eG Hemostatic Forceps Product
 Table 164. Medicon eG Recent Developments/Updates
 Table 165. J & J Instruments Company Information
 Table 166. J & J Instruments Description and Business Overview
 Table 167. J & J Instruments Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 168. J & J Instruments Hemostatic Forceps Product
 Table 169. J & J Instruments Recent Developments/Updates
 Table 170. American Diagnostic Company Information
 Table 171. American Diagnostic Description and Business Overview
 Table 172. American Diagnostic Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 173. American Diagnostic Hemostatic Forceps Product
 Table 174. American Diagnostic Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Hemostatic Forceps Distributors List
 Table 178. Hemostatic Forceps Customers List
 Table 179. Hemostatic Forceps Market Trends
 Table 180. Hemostatic Forceps Market Drivers
 Table 181. Hemostatic Forceps Market Challenges
 Table 182. Hemostatic Forceps Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hemostatic Forceps
 Figure 2. Global Hemostatic Forceps Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Hemostatic Forceps Market Share by Type: 2025 & 2032
 Figure 4. Halstead Mosquito Hemostatic Forceps Product Picture
 Figure 5. Kelly and Crile Hemostatic Forceps Product Picture
 Figure 6. Rochester-Carmalt Hemostatic Forceps Product Picture
 Figure 7. Global Hemostatic Forceps Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Hemostatic Forceps Market Share by Application: 2025 & 2032
 Figure 9. Surgical
 Figure 10. Dissection
 Figure 11. Dental
 Figure 12. Laparoscopic
 Figure 13. Others
 Figure 14. Global Hemostatic Forceps Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Hemostatic Forceps Market Size (US$ Million), 2021–2032
 Figure 16. Global Hemostatic Forceps Sales (K Units), 2021–2032
 Figure 17. Global Hemostatic Forceps Average Price (USD/Unit), 2021–2032
 Figure 18. Hemostatic Forceps Report Years Considered
 Figure 19. Hemostatic Forceps Sales Share by Manufacturers in 2025
 Figure 20. Global Hemostatic Forceps Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Hemostatic Forceps Players: Market Share by Revenue in Hemostatic Forceps in 2025
 Figure 22. Hemostatic Forceps Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Hemostatic Forceps Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Hemostatic Forceps Sales Market Share by Country (2021–2032)
 Figure 25. North America Hemostatic Forceps Revenue Market Share by Country (2021–2032)
 Figure 26. U.S. Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Hemostatic Forceps Sales Market Share by Country (2021–2032)
 Figure 29. Europe Hemostatic Forceps Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Hemostatic Forceps Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Hemostatic Forceps Revenue Market Share by Region (2021–2032)
 Figure 37. China Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Indonesia Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Thailand Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Malaysia Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Hemostatic Forceps Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Hemostatic Forceps Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Hemostatic Forceps Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Hemostatic Forceps Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE Hemostatic Forceps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Hemostatic Forceps by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Hemostatic Forceps by Type (2021–2032)
 Figure 58. Global Hemostatic Forceps Price (USD/Unit) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Hemostatic Forceps by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Hemostatic Forceps by Application (2021–2032)
 Figure 61. Global Hemostatic Forceps Price (USD/Unit) by Application (2021–2032)
 Figure 62. Hemostatic Forceps Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS